About bioMérieux
bioMérieux is a global leader in the field of in vitro diagnostics, dedicated to improving public health by providing innovative diagnostic solutions. For physicians, bioMérieux offers a comprehensive portfolio of tests and systems designed to detect and diagnose infectious diseases, monitor patient conditions, and support antimicrobial stewardship. Their advanced technologies, such as multiplex PCR panels and automated identification and susceptibility testing systems, enable rapid and accurate results, empowering clinicians to make timely and informed treatment decisions. This is crucial in managing critical conditions like sepsis, respiratory infections, and vaginitis, where early and precise diagnosis can significantly impact patient outcomes and reduce the spread of antimicrobial resistance.
The company’s commitment extends beyond infectious diseases to encompass food safety and pharmaceutical quality control, ensuring the health and well-being of consumers and patients. Through continuous innovation and strategic partnerships, bioMérieux strives to address the evolving challenges in healthcare, providing tools that enhance laboratory efficiency, improve patient care, and contribute to a healthier world. Their focus on research and development ensures that healthcare professionals have access to cutting-edge diagnostic capabilities to tackle emerging health threats and optimize patient management.
Focus Areas
Business Intelligence
| Technology | molecular biology, microbiology, immunoassays, PCR molecular panels, syndromic molecular diagnosis, next-generation sequencing (NGS), AI models for genomic analysis |
What Physicians Need to Know
Leverage rapid diagnostic tools like BIOFIRE® FILMARRAY® panels for timely results in infectious disease cases, especially for gastrointestinal infections. Utilize PCT-guided therapy with VIDAS® B•R•A•H•M•S PCT™ for optimized patient management in 20 minutes. Consider VITEK® MS PRIME for advanced microbial identification to guide appropriate antibiotic therapy and combat antimicrobial resistance.
The company offers digital solutions and connectivity options, including the BIOMÉRIEUX+ platform, to streamline order management, account details, and support, facilitating integration into laboratory workflows.
Videos
News, demos, and interviews about bioMérieux.
Videos load interactively. If none appear, search YouTube for bioMérieux →
Frequently Asked Questions
Related Companies
PathologyAILab offers advanced digital cytology services, leveraging a multi-agent AI system for cervical cancer diagnosis. This innovative solution provides comprehensive image analysis to deliver precise and reliable diagnostic insights to healthcare professionals. The service aims to provide rapid results, typically within 2-4 hours, for urgent cases, enabling timely clinical decisions. The process involves submitting digital […]
Ottobock Healthcare Products, an international company based in Duderstadt, Germany, is a global leader in orthopedic technology, specializing in prosthetics, orthotics, wheelchairs, and exoskeletons. Founded in 1919, the company’s mission is to restore and improve independence for individuals with mobility challenges through technological innovation, advanced biomechanics, and advancements in neuromobility. They offer a comprehensive portfolio […]
Bonraybio Co., Ltd. (stock code: 6955) is dedicated to advancing medical innovation and focusing on health, aiming to enhance global medical quality in the reproductive field. The company specializes in providing comprehensive solutions for male infertility, recognizing the increasing challenges posed by aging populations and rising infertility rates worldwide. Their mission is to address the […]
Vitestro is a healthcare AI company that has developed Aletta®, the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). This device automates the diagnostic blood collection process, aiming to set a new standard for blood collection. Vitestro’s technology is designed to address global challenges in manual phlebotomy, such as staffing constraints, heavy workloads, and variability in […]
